Several analysts have recently updated their ratings and price targets for Praxis Precision Medicines (NASDAQ: PRAX): 5/8/2026 – Praxis Precision Medicines was given a new $420.00 price target by Deutsche Bank Aktiengesellschaft. 5/8/2026 – Praxis Precision Medicines had its price target raised by Wedbush from $130.00 to $166.00. They now have an “underperform” rating on […]